Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 6.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 6.91% | |||
| Cost of Revenue | 0.00% | 8.82% | |||
| Gross Profit | 0.00% | 5.75% | |||
| SG&A Expenses | 0.00% | 7.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 48.91% | |||
| Total Operating Expenses | 0.00% | 8.42% | |||
| Operating Income | 0.00% | -9.20% | |||
| Income Before Tax | 0.00% | 21.02% | |||
| Income Tax Expenses | 0.00% | 48.19% | |||
| Earnings from Continuing Operations | 0.00% | 17.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 38.22% | |||
| Net Income | 0.00% | 29.42% | |||
| EBIT | 0.00% | -9.20% | |||
| EBITDA | 0.00% | -6.59% | |||
| EPS Basic | 0.00% | 29.06% | |||
| Normalized Basic EPS | 0.00% | 2.70% | |||
| EPS Diluted | 0.00% | 29.06% | |||
| Normalized Diluted EPS | 0.00% | 2.70% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.00% | -- | |||